FDA
-
-
-
-
-
-
-
FDA approves Cablivi for rare blood disorder in kids
-
-
-
-
-
-
-
Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
-
-
-
-
-
-
-
FDA removes safety restrictions for Sanofi thyroid cancer drug
-
-
-
-
-
-
-
Sanofi (SNY) to acquire Vigil Neuroscience
-
-
-
-
-
-
-
Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)
-
-
-
-
-
-
-
Sanofi (SNY) adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season
-
-
-
-
-
-
-
Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

